
Building AI - Powered Solutions for Rapid, Accurate, Cost-Effective Bacteria Analysis
The Company
Fighting deadly pathogens and anti-microbial resistant bacteria (AMR) is a major global challenge. Our MedTech startup, BioKubes™ registered in Delaware, USA, has developed an advanced rapid bacteria identification technology.
Lessening AMR’s impact will require incremental contributions from the global research community. Our fully automated platform combines advanced bioimaging, robotics, and machine learning classification to produce rapid cost-effective bacteria screenings.
The BioKubes™ user-friendly design allows microbiology and non-microbiology researchers (genomics, pharma, environment, medicine) to conduct highly accurate multi-dimensional bacteria analysis.
BioKubes' expansion plan will produce new hardware/software applications developed internally or in partnership with research institutions and innovative startups in an open innovation partnership.
The Solution



Higher
-
Accuracy
-
Output
-
Consistency
Lower
-
Human Error
-
Cross Contamination
-
Cost
Easier
-
Data Sharing
-
Collaboration
-
Documentation

The Validation

Partners


Collaborators


LIG Grenoble
Informatics Laboratory


The Team


Ahmed Alsoffi, CTO
Dr. Reem Tambosi, CEO

Robin Freeman, Operations
Research Partners

Dr. Ahmad Lbath, President, Smart Computing, Carnot Institute

Dr. Max Maurin, Lab Director, CHU-UGA

Dr. Walid Rachidi, Vice Dean, Pharmacy UGA